Serotonin reuptake inhibitors (SSRI) have been associated with a state of restlessness, lability, agitation, and anxiety termed<unk> ". In some people, this state change can increase suicidal tendencies, especially in those under age 25 and during the initial weeks of treatment. SSRI-induced<unk>  is well-accepted by clinicians. Evidence reveal that jitteriness/anxiety syndrome predicts an improved prognosis (level D).<unk>  resolves within hours of discontinuing the serotonergic agent and initiating care. However, resolution of symptoms may be slightly longer in those taking medications with longer half-lives, such as monoamine oxidase inhibitors (MAOIs).
Activation syndrome
Cytokine release syndrome
Cryptic shock
Tumor lysis syndrome
Ischemic cascade
Post-intensive care syndrome
Distributive shock
Second-impact syndrome